Recerca

Àrea 5

Fisiopatologia i bases moleculars en hematologia

Articles de l'any 2010
Original

Originals publicats: 14

Factor d'impacte: mitjana: 5.61, total: 78.59

  • Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

    Fernandez V, Salamero O, Espinet B, Sole F, Royo C, Navarro A, Camacho F, Bea S, Hartmann E, Amador V, Hernandez L, Agostinelli C, Sargent RL, Rozman M, Aymerich M, Colomer D, Villamor N, Swerdlow SH, Pileri SA, Bosch F, Piris MA, Montserrat E, Ott G, Rosenwald A, Lopez-Guillermo A, Jares P, Serrano S, Campo E
    CANCER RES. 2010; 70: 1408-1418. IF: 7.543

  • A Somatic NLRP3 Mutation as a Cause of a Sporadic Case of Chronic Infantile Neurologic, Cutaneous, Articular Syndrome/Neonatal-Onset Multisystem Inflammatory Disease Novel Evidence of the Role of Low-Level Mosaicism as the Pathophysiologic Mechanism Under

    Arostegui JI, Saldana MDL, Pascal M, Clemente D, Aymerich M, Balaguer F, Goel A, DelCastillo CF, Rius J, Plaza S, Robledillo JCL, Juan M, Ibanez M, Yague J
    ARTHRITIS RHEUM-US. 2010; 62: 1158-1166. IF: 7.332

  • In vitro and In vivo Selective Antitumor Activity of Edelfosine against Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia Involving Lipid Rafts

    Mollinedo F, DeLaIglesia-Vicente J, Gajate C, DeMendoza AEH, Villa-Pulgarin JA, DeFrias M, Roue G, Gil J, Colomer D, Campanero MA, Blanco-Prieto MJ
    CLIN CANCER RES. 2010; 16: 2046-2054. IF: 6.747

  • Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group

    Cervantes F, Lopez-Garrido P, Montero MI, Jonte F, Martinez J, Hernandez-Boluda JC, Calbacho M, Sureda A, Perez-Rus G, Nieto JB, Perez-Lopez C, Roman-Gomez J, Gonzalez M, Pereira A, Colomer D
    HAEMATOL-HEMATOL J. 2010; 95: 1317-1324. IF: 6.416

  • Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia ("accelerated" chronic lymphocytic leukemia) with aggressive clinical behavior

    Gine E, Martinez A, Villamor N, Lopez-Guillermo A, Camos M, Martinez D, Esteve J, Calvo X, Muntanola A, Abrisqueta P, Rozman M, Rozman C, Bosch F, Campo E, Montserrat E
    HAEMATOL-HEMATOL J. 2010; 95: 1526-1533. IF: 6.416

Revisió

Revisions publicades: 2

Factor d'impacte: mitjana: 3.82, total: 7.65

  • Cell Death Targeting Therapies in B Lymphoid Malignancies

    Saborit-Villarroya I, Roue G, Lopez-Guerra M, Alonso R, Xargay-Torrent S, Rosich L, Colomer D
    CURR DRUG TARGETS. 2010; 11: 769-780. IF: 3.932

  • NF-kappa B as a therapeutic target in chronic lymphocytic leukemia

    Lopez-Guerra M, Colomer D
    EXPERT OPIN THER TAR. 2010; 14: 275-288. IF: 3.713

Més articles